about
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.Characteristics of oral mucosal events related to bevacizumab treatment.Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.Brain metastases: epidemiology and pathophysiology.Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma.Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients.A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.Temozolomide or bevacizumab for spinal cord high-grade gliomas.Nervous system metastases from malignant mesothelioma.Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas.Pearls: primary brain tumors.Primary central nervous system lymphoma
P50
Q30361848-59DAC7B4-0DD7-493F-93B7-B469F628D313Q33384898-F86214EC-5F5D-4CF8-8A3C-78B11494A11AQ35126247-23A02281-8015-49B7-B25C-F5ECBCE38C0CQ35776273-ED5012F6-4BBB-467B-90BC-A6DD52C90CD7Q35911026-79657935-C2CC-4F26-89A8-78122354A718Q36282137-2194487D-580F-44FC-A2D2-298A02844447Q36544101-21A368D2-FB48-403B-980E-C25AF247B55EQ36785131-88183AC2-0DB6-4A90-8668-7526D8D7C240Q36893250-D21E5D82-7DE2-4C25-8778-2CFFD7290FFAQ38017139-BC6DB1C8-4D25-4AC2-8D19-8737A18ABC0BQ44979907-CDC0937E-6244-464A-B7D4-96F761B04B27Q48125310-737BC359-5D8D-4B13-8D81-96925F324B41Q48322909-3E46449F-5398-432D-8174-B8F4373EFCEBQ80413165-FA099198-DD6B-493D-8A59-4C9F62BEF08D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Igor T Gavrilovic
@ast
Igor T Gavrilovic
@en
Igor T Gavrilovic
@es
Igor T Gavrilovic
@nl
Igor T Gavrilovic
@sl
type
label
Igor T Gavrilovic
@ast
Igor T Gavrilovic
@en
Igor T Gavrilovic
@es
Igor T Gavrilovic
@nl
Igor T Gavrilovic
@sl
prefLabel
Igor T Gavrilovic
@ast
Igor T Gavrilovic
@en
Igor T Gavrilovic
@es
Igor T Gavrilovic
@nl
Igor T Gavrilovic
@sl
P106
P21
P31
P496
0000-0001-9104-6132